language_icon
EN
HI

Curis Lifesciences Share price

CURIS

117.9

5.90 (5.27%)
Last updated on 23 Apr, 2026 | 15:31 IST
Today's High

118.00

Today's Low

115.50

52 Week Low

83.60

52 Week High

147.90

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Curis Lifesciences Chart

Curis Lifesciences Share Key Metrics

Volume
9000.00
Market Cap
95.32 CR
LTQ@LTP
1000@117.90
ATP
117.18
Var Margin
53.5 %
Circuit Range
89.6-134.4
Delivery %
- %
Value
10.55 L
ASM/GSM
No
Market Lot
1000

Summary

23 Apr, 2026 | 15:31 को, Curis Lifesciences का शेयर प्राइस आज ₹117.9 पर है, जो दिन के लिए 5.90% की 5.27 दर्शाता है। स्टॉक की इंट्राडे मूवमेंट ₹115.50 और ₹118.00 के बीच रही है, जबकि 52‑सप्ताह के आधार पर यह ₹83.60 से ₹147.90 तक रही है। ट्रेडिंग गतिविधि के मामले में, Curis Lifesciences ने 9000 शेयरों का वॉल्यूम रिकॉर्ड किया है, जिसका मार्केट कैपिटलाइज़ेशन ₹8084434 है। स्टॉक की एवरेज ट्रेडेड प्राइस ₹11718 है, जबकि लास्ट ट्रेडेड क्वांटिटी एट लास्ट ट्रेडेड प्राइस (LTQ@LTP) 1000,11790 रही। यह स्टॉक ₹89.6-134.4 की सर्किट रेंज में ट्रेड करता है, और आज का कारोबार मूल्य ₹10.55 L है। दिन के लिए डिलीवरी परसेंटेज -1% रही। इसके अतिरिक्त, Curis Lifesciences वर्तमान में No फ्रेमवर्क के तहत आता है और 1000 के मार्केट लॉट साइज़ में ट्रेड करता

Curis Lifesciences Fundamentals

View More
P/E Ratio

0

P/B Ratio

0

Div. Yield

0

Sector P/E

64.34

Sector P/B

3.51

Sec. Div. Yield

0.57

Curis Lifesciences Resistance and Support

Pivot 112

Resistance

First Resistance

112

Second Resistance

112

Third Resistance

112

Support

First Support

112

Second Support

112

Third Support

112

Curis Lifesciences Shareholding Pattern

View More
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

68.03%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

1.19%

Domestic Institutional Investors

4.35%

Retail

26.43%

Others

0%

Total Promoters
MAR '26
68.03%

Curis Lifesciences Corporate Actions

DateAgenda
No Data Found

Curis Lifesciences News

Curis Lifesciences Limited (CURIS)

Curis Lifesciences announces the resignation of Independent Director Ms. Dhruvi Shyam Kapadia, effective April 1, 2026. The resignation is due to her pre-occupancy and increased professional commitments, with no other material reasons cited.
Mar 31 2026 18:03:00

Curis Lifesciences Limited (CURIS)

Dhruvi Kapadia has resigned as an Independent Director of Curis Lifesciences, effective April 1, 2026. The resignation is attributed to pre-occupancy and increased professional commitments, with the company initiating necessary regulatory filings.
Mar 31 2026 18:03:00

Curis Lifesciences Limited (CURIS)

Curis Lifesciences announced the resignation of Independent Director Dhruvi Shyam Kapadia, effective April 1, 2026. Her resignation is attributed to pre-occupancy and increased professional commitments, with no other material reasons cited.
Mar 31 2026 18:03:00

Curis Lifesciences Limited (CURIS)

Curis Lifesciences board approved acquiring a 51% stake in Uninova Lifesciences for ₹20.65 lakh cash, making it a subsidiary. This expands the company's presence in the pharmaceutical industry. The acquisition is expected to be completed within 30 days.
Mar 30 2026 17:03:00

Curis Lifesciences Limited (CURIS)

Curis Lifesciences board approved acquiring a 51% stake in Uninova Lifesciences for ₹20.65 lakh cash, making it a subsidiary. This expands the company's presence in the pharmaceutical industry. The acquisition is expected to be completed within 30 days.
Mar 30 2026 17:03:00

Curis Lifesciences Limited (CURIS)

Curis Lifesciences appointed NGST & Associates as its internal auditor and Sachin Thakkar & Associates as its secretarial auditor, both for a 1-year term. These appointments are effective March 28, 2026, strengthening the company's audit and compliance functions.
Mar 30 2026 16:03:00

Curis Lifesciences Limited (CURIS)

Curis Lifesciences board approved acquiring a 51% stake in Uninova Lifesciences for ₹20.65 lakh cash, making it a subsidiary. This expands the company's presence in the pharmaceutical industry. The acquisition is expected to be completed within 30 days.
Mar 30 2026 16:03:00

Curis Lifesciences Limited (CURIS)

Curis Lifesciences agreed to a strategic investment in Uninova Lifesciences Private Limited, acquiring a 51% equity stake for ₹20.65 lakhs. This move aims to expand its business and diversify its market presence in the pharmaceutical industry.
Mar 30 2026 15:03:00

Curis Lifesciences Limited (CURIS)

Curis Lifesciences agreed to a strategic investment in Uninova Lifesciences Private Limited, acquiring a 51% equity stake for ₹20.65 lakhs. This move aims to expand its business and diversify its market presence in the pharmaceutical industry.
Mar 30 2026 15:03:00
Read More

About Curis Lifesciences AboutThe

NSE : 759825  
BSE : 0  
ISIN : INE1BZN01016  

Our Company was originally formed and registered as a Partnership Firm under the Partnership Act 1932 (“Partnership Act”) in the name and style of “M/s Loreto Pharmaceutacals” pursuant to a deed of partnership dated June 2 2010. Thereafter " M/s Loreto Pharmaceuticals” was converted from Partnership Firm to a Private Limited Company under the Companies Act 2013 in the name of “Curis Lifesciences Private Limited” and received a certificate of incorporation datedMarch 23 2016 issued by Assistant Registrar of Companies Gujarat. Subsequently our Company was converted into a public limited company and the name of our Company was changed from “Curis Lifesciences Private Limited” to “Curis Lifesciences Limited” vide Special Resolution dated May 6 2024 the status of the Company was changed to public limited and the fresh certificate of incorporation consequent to conversion bearing Corporate Identification Number U24230GJ2016PLC086559 was issued on August 9 2024 by the Assistant Registrar of Companies/ Deputy Registrar of Companies/ Registrar of Companies Central Processing Centre. From year 2010 to 2016 our partnership firm was engaged in the marketing and trading of various pharmaceutical products. As a partnership firm our product portfolio included tablets capsules oral liquids creams ointments injections lotions oral powders and other nutraceuticals products. We procured finished goods from manufacturers and distributed them to various wholesalers and other clients throught the country.MAJOR EVENTS:2011- Started Business by starting a Partnership Firm with two Partners in name of "M/s Loreto Pharmaceutical" by Mr. Dasharathbhai Patel and Mr. Piyush Gordhanbhai Antala.2016- The Partnership Firm got converted into Private Company post conversion and receiving Certificate of Incorporation on March 23rd 2016.2018- The Company received FDA License for manufacturing Pharma products.2019- The Company availed Kenya PPC board approval and approval from Ministry of Health - Republic of Yemen State Good Manufacturing Practices and GLP licence from Local FDA2020- The Company received WHO GMP certificate.2021- The Company received FDA Approval from Philippines during the tragic era of COVID-192022- Renewal of the WHO Certificates and Nigeria NAFDAC Approval2023- Retention of FDA License for manufacturing Pharma products.2025- Conversion From Private Limited into Public Limited company.

Read More

Curis Lifesciences Management

NamePosition
Nikhil PurohitCompany Secretary & Compliance Officer
Dharmesh Dasharathbhai PatelChairman & Managing Director
View More

Curis Lifesciences Similar Stocks

No Data Found

Curis Lifesciences FAQs

Curis Lifesciences शेयर का खरीद मूल्य 117.9 है। लाइव प्राइस और तत्काल ट्रेडिंग के लिए, आप अपने चॉइस ट्रेडिंग खाते में लॉगिन कर सकते हैं या चॉइस के साथ मुक्त डीमैट खाता खोल सकते हैं।

Curis Lifesciences शेयर खरीदने के लिए अपने चॉइस ट्रेडिंग खाते में लॉगिन करें, या चॉइस डीमैट खाता खोल, फिर फंड जोड़ें, कंपनी का नाम खोजें, अपना ऑर्डर टाइप चुनें और ट्रेड प्लेस करें।

Curis Lifesciences शेयर का प्राइस-टू-अर्निंग्स (पी/ई) रेशियो 0 है। आप सापेक्ष मूल्यांकन के लिए इसकी तुलना सेक्टर के औसत से कर सकते हैं।

Curis Lifesciences शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 0 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Curis Lifesciences शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 3.51 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Curis Lifesciences का मार्केट कैप 95.32 CR है। यह कंपनी के आकार की श्रेणी और ट्रेडिंग लिक्विडिटी को दर्शाता है।

Curis Lifesciences शेयर का 52 सप्ताह का उच्चतम और न्यूनतम मूल्य 147.90 और 83.60 है। ये मूल्य मूल्य सीमाएं, ट्रेडिंग रेंज, अस्थिरता, संभावित सपोर्ट/रेजिस्टेंस और मूल्य गति को दर्शाते हैं।

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost